Back
ESC Premium Access

Antiarrhythmic effect of ranolazine in combination with selective NCX-inhibition in an experimental model of atrial fibrillation

Session: Atrial Fibrillation ePosters
Topic: Rhythm Control, Antiarrhythmic Drugs
Speaker: Doctor J. Wolfes (Munster, DE)
Event: ESC Congress 2020

Congress Presentation

Add to my library

Like

About the speaker

Doctor Julian Wolfes

University Hospital of Munster, Munster (Germany)
0 follower

172 more presentations in this session

Atrial fibrillation with or without structural abnormalities. Analysis from a nationwide database.

Speaker: Doctor V. Mertz (FR)

Access
Abstract
Slides
Like
Thumbnail

Epicardial adipose tissue and atrial fibrillation: guilty as charged or guilty by association?

Speaker: Doctor J. Sousa (Funchal, PT)

Access
Abstract
Slides
Like
Thumbnail

Timing and degree of left atrial stunning and reverse functional remodeling following electrical cardioversion in patients with recent onset atrial fibrillation

Speaker: Doctor P. Arvanitis (Uppsala, SE)

Access
Abstract
Slides
Like
Thumbnail

Irregular beat-to-beat hemodynamic properties determine left ventricular function during atrial fibrillation

Speaker: Doctor A. Lyon (Maastricht, NL)

Access
Abstract
Slides
Like
Thumbnail

Genetic susceptibility, elevated blood pressure and risk of atrial fibrillation

Speaker: Mr M. Nazarzadeh (Oxford, GB)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Atrial Fibrillation ePosters

Speakers: Doctor J. Wolfes, Doctor V. Mertz, Doctor J. Sousa, Doctor P. Arvanitis, Doctor A. Lyon...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources